Catalent
CTLT
#1759
Rank
ยฃ8.79 B
Marketcap
ยฃ48.48
Share price
0.00%
Change (1 day)
13.49%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -ยฃ5.08

According to Catalent's latest financial reports the company's current EPS (TTM) is -ยฃ4.83. In 2023 the company made an earnings per share (EPS) of -ยฃ5.19 a decrease over its 2022 EPS that were of ยฃ1.73.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-ยฃ5.08-2.11%
2023-ยฃ5.19-399.56%
2022ยฃ1.73-30.58%
2021ยฃ2.5079.67%
2020ยฃ1.39114.12%
2019ยฃ0.65-15%
2018ยฃ0.7675.44%
2017ยฃ0.44-22.97%
2016ยฃ0.57-59.56%
2015ยฃ1.40282.05%
2014ยฃ0.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-ยฃ0.58-87.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
ยฃ2.77-157.35%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-ยฃ0.57-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
-ยฃ1.13-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA